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Abstract Hypusine synthesis in the eukaryotic initiation factor 
5A is a unique two-step posttranslational modification. After 
deoxyhypusine is generated by the deoxyhypusine synthase, the 
deoxyhypusine hydroxylase (EC 1.14.99.29) catalyzes the forma- 
tion of mature hypusine. A rapid assay for monitoring the de- 
oxyhypusine hydroxylase activity was established, employing the 
oxidative cleavage of the hypusyl residue and subsequent extrac- 
tion of the generated aldehydes. As metal ion chelators have been 
reported to inhibit the deoxyhypusine hydroxylase, the mecha- 
nism of this inhibition and the effect of transition metal ions on 
the enzyme activity were investigated. A ferric ion appears to be 
essential for enzymatic activity, the inhibition of which is entirely 
attributed to the metal ion binding capacity of the chelators. 
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1. Introduction 
Eukaryotic initiation factor 5A (eIF-5A) with its unique 
amino acid hypusine is highly conserved in all eukaryotes and 
in archaebacteria, but could not be found in eubacteria. Even 
though the precise in vivo function of this protein is still un- 
known, hypusine formation in eIF-5A was shown to be central 
to cell viability [1-3]. 
The posttranslational modification which leads to the bio- 
synthesis of the amino acid hypusine in eIF-5A is a two-step 
process. In the first step, the aminobutyl moiety of spermidine 
is transferred to the e-amino group of a specific lysyl residue 
(at amino acid position 50 in human eIF-5A) in an NAD +- 
dependent manner. This reaction is catalyzed by the enzyme 
deoxyhypusine synthase. Further modification of the resulting 
deoxyhypusine intermediate by the deoxyhypusine hydroxylase 
generates the mature hypusine-containing eIF-5A (for review 
see [4]). The deoxyhypusine synthase from Neurospora crassa 
[5], rat [6], and man [7] was recently purified and biochemically 
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characterized and the genomic DNA sequence ncoding the 
deoxyhypusine synthase in Saccharomyces cerevisiae has been 
identified [7,8]. cDNA cloning and expression of the recombi- 
nant human deoxyhypusine synthase was published recently 
[9,10]. 
However, little is known about the second enzyme of the 
hypusine biosynthesis pathway deoxyhypusine hydroxylase. In- 
hibition studies indicated that this enzyme can be inactivated 
by both metal chelators [11,12] and polyamines [13]. Further- 
more, the inhibition of the deoxyhypusine hydroxylase in vivo 
correlates with cell cycle arrest at the G I/S boundary [14,15]. 
Most studies on deoxyhypusine hydroxylase activity in vitro 
[12,13] and in vivo [14-16] made use of amino acid composition 
analysis [2,17], which allows the distinction between de- 
oxyhypusine and hypusine. Another method for discriminating 
between the two modification states is based on the specific 
oxidation of the hypusyl residue [18]. In the work presented 
here, a novel and rapid in vitro assay for monitoring the de- 
oxyhypusine hydroxylase activity is described. This assay is 
based on mild oxidation of the product, i.e. the hypusine resi- 
due [19] and subsequent selective xtraction of the generated 
aldehydes with organic solvent [20]. Using this assay, we were 
able to analyze the mode of inhibition of the metal chelators 
and the specificity of the metal ion dependency of the human 
deoxyhypusine hydroxylase from HeLa cells in vitro. 
2. Materials and methods 
2.1. Material~ 
HeLa $3 cells were purchased from the Computer Cell Culture Cen- 
tre, University of Mons, Belgium. Chromatography materials and col- 
umns were purchased from Pharmacia, Freiburg, Germany. [14C]Sper- 
midine trihydrochloride (N-(3-aminopropyl)-[l,4J4C]tetramethylene - 
1,4-diamine trihydrochloride) with a specific activity of 114 mCi/mmol 
was from Amersham Int. plc, Little Chalfont, England, UK. [3H]Sper- 
midine trihydrochloride ([terminal methylenes-3H](N-(3-aminopropyl)- 
tetramethylene-1,4-diamine trihydrochloride) with a specific activity of 
16.4 Ci/mmol was obtained from DuPont NEN, Dreieich, Germany. 
Metipirox and the derivative of Ciclopiroxolamine (CPX), 4,6-di- 
phenyl-l-hydroxy-pyridine-2-one (DPHP) were synthesized as previ- 
ously published [21]. CPX, mimosine, cc,~'-dipyridyl, sodium meta- 
periodate, 6-hydroxylysine hydrochloride, and dimedone(5,5-dimethyl- 
1,3-cyclo-hexanedione) w re from Sigma Chemical Co., St. Louis, 
USA, spermidine (non-radioactive) was from Calbiochem, and NAD ÷ 
from Boehringer-Mannheim Corp., Germany. All other eagents were 
of analytical grade. 
2.2. Preparation o.1' deoxyhypusine-containing elF-5A substrate 
In order to generate radioactively labeled eoxyhypusine-containing 
eIF-5A as substrate for the deoxyhypusine hydroxylase assay, purified 
recombinant eIF-5A precursor protein [22] was enzymatically modi- 
fied. With minor modifications, this reaction was carried out as de- 
scribed previously, using the human deoxyhypusine synthase (spermid- 
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ine dehydrogenase, NAD +, l-deoxyhypusyl-forming and aminobutyl- 
transferring) purified from HeLa cells [23]. The standard reaction mix- 
ture contained either 44,uM [~4C]spermidine or [3H]spermidine (diluted 
with non-radioactive spermidine to a specific activity of 440 mCi/ 
mmol), 2.5 mM NAD +, 3 #M recombinant eIF-5A precursor protein 
and 6 units of deoxyhypusine synthase in 0.3 M glycine/NaOH buffer, 
pH 9.0, 1 mM DTT and was incubated for 3 h at 37°C. (One unit is 
defined as the amount of enzyme which catalyzes the formation of 
1 pmol of product per 3 h under the given condition). For separation 
of labeled eIF-5A from excess spermidine, 300 #1 aliquots of the reac- 
tion mixture were passed over Sephadex G-25 M gel filtration columns 
(PD-10 columns, Pharmacia), which were equilibrated with 50 mM 
sodium phosphate buffer, pH 7.5, 6 mM DTT. After measuring the 
incorporated radioactivity in a liquid scintillation counter, aliquots 
containing 22,500 cpm of labeled eIF-5A were frozen at -20°C. Ap- 
proximately 70% of the eIF-5A molecules are modified to their de- 
oxyhypusine-containing form as judged by mass spectrometry. 
2.3. Deoxyhypusine hydroxylase assay 
The deoxyhypusine hydroxylase uses deoxyhypusine-containing eIF- 
5A as its natural substrate to form hypusine-modified IF-5A. This 
product can be oxidized to yield the free lysine form ofeIF-5A (precur- 
sor), formaldehyde and fl-aminopropionaldehyde [18]. Following oxi- 
dative cleavage, the generated radioactively abeled aldehydes can be 
specifically converted with dimedone, and extracted into the organic 
phase in analogy to the methods previously described for hydroxyprolyl 
and hydroxylysyl residues [20]. 
HeLa cell extracts were prepared as previously described [23]. Briefly, 
35 g of HeLa cells were resuspended in 280 ml of 10 mM Tris-HCl, pH 
7.0, 10 mM NaC1, 5 mM DTT, 1 mM phenylmethylsulfonyl fluoride, 
10 #g/ml aprotinin, and 10 ,ug/ml leupetin, and disrupted in a Dounce 
homogenizer. After centrifugation at40,000 x g for 10 min at 4°C the 
clear supernatant was frozen in liquid nitrogen. 
250 #1 of HeLa cell extract were incubated at 37°C for 3 h in 50 mM 
sodium phosphate buffer, pH 7.5, containing 6 mM DTT and 22,500 
cpm of labeled deoxyhypusine-containing eIF-5A (~80 nm). All steps 
following this hydroxylase reaction were conducted at room tempera- 
ture. After diluting the sample with 2 vols. of 45 mM citric acid and 210 
mM Na2HPO4, 6-hydroxylysine hydrochloride was added as a carrier 
to a concentration of 1.25 mM. The oxidation of the hydroxylated 
amino acids to their aldehyde forms was then carried out using sodium 
meta-periodate at a final concentration of 50 mM. Upon addition of 
dimedone (5,5-dimethyl-l,3-cyclo-hexanedione) t  a final concentra- 
tion of 80 mM, the generated aldehydes were converted into toluene- 
soluble compounds. Following extraction of the modified aldehydes 
with one volume of toluene by vigorous haking for 30 min and subse- 
quent centrifugation for 10 rain at 1500xg, the radioactivity in the 
organic phase was measured in a liquid scintillation counter. 
2.4. Spectrophotometric competition titration 
The EDTA-Fe(III) complex was formed by incubating 30 #M 
Fe(NO3)3 in phosphate-buffered saline (10 mM sodium phosphate at 
pH 7.2, 150 mM NaCI) at 37 o C for 16 h with various concentrations 
of EDTA (1 #M~00 mM). After CPX, metipirox, or DPHP, respec- 
tively, were added to a final concentration of 100 #M, incubation was 
continued for 3 h. Following an extraction with ethylacetate, the ab- 
sorption of the organic phase was determined in a Beckman DU-65 
spectrophotometer at 410 nm. For the titration of the EDTA-Fe(III) 
complex with mimosine, 10-fold higher concentrations of the EDTA 
Fe(II1) complex were used and the absorption of the aqueous phase was 
measured at 445 nm. The relative Ka value for ~,c~-dipyridyl was deter- 
mined by titration of its Fe(III) complex with mimosine. Based on these 
titration curves the dissociation constant for the ligand from Fe(III) in 
relation to the known dissociation constant for the competitor EDTA 
from Fe(III) was calculated. The K d for the reaction [3 ligand 
+ Fe(III) ~ (ligand)3Fe(III)] determined by the algebraically correct 
description of the binding equilibria in a mixture of competing ligands 
[24] extended with the possibility for variable stochiometries between 
the ligands and substrate, is the intrinsic site dissociation constant for 
the case of the ligand binding to 3 equivalent non-interacting sites on 
Fe(Ill). The resulting Kd values for the different chelators show that the 
estimation of equivalent extinction coefficients for 3 (ligand)3Fe(III) 
complexes provides an appropriate degree of sensitivity to structural 
variations between the ligands. 
3. Results and discussion 
The oxidative cleavage of the hypusyl residue allows its spe- 
cific distinction from the deoxyhypusyl residue [18]. Harsh ox- 
idation conditions using permanganate and periodate leads to 
the formation of the lysine form of eIF-5A, formic acid and 
fl-alanine. However, formaldehyde and f l -aminopropionalde- 
hyde are produced instead of the carbonic acids, if only peri- 
odate is employed in the oxidation [19]. These aldehydes can 
be specifically extracted with toluene following their incorpora- 
tion into dimedone dimers [20]. Based on the oxidation of the 
radioactively labeled hypusyl residue and subsequent extrac- 
tion of the generated aldehydes, a rapid assay for measuring the 
deoxyhypusine hydroxylase activity has been developed. The 
specificity of this assay is proven by the following control exper- 
iments. (1) In the absence of the deoxyhypusine hydroxylase 
containing cell extract, no radioactivity above background was 
found in the toluene phase (Table 1), which confirms the re- 
quirement for the hydroxyl group for the oxidative cleavage 
reaction and the specificity of the oxidation for a mature hy- 
pusyl residue. (2) No radioactivity above background was 
found in the toluene phase, in the case where NaIO4 was omit- 
ted from the oxidation reaction. (3) Measurable hydroxylase 
activity is only observed in the presence of the substrate de- 
oxyhypusine-containing eIF-5A. Equivalent amounts of free 
labeled spermidine plus unmodified precursor elF-5A resulted 
in the extraction of only minute amounts of radioactivity into 
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Fig. 1. Concentration-dependent inhibition of the deoxyhypusine hy- 
droxylase by various metal chelators. EDTA, mimosine, and ~,c~-dipy- 
ridyl were dissolved in PBS; CPX, metipirox, and DPHP were dissolved 
in 40% ethanol. Corresponding amounts of the chelators were added 
to the cell extracts prior to incubation with the [3H]deoxyhypusine- 
containing substrate. The hydroxylase reaction was performed in 50 
mM potassium phosphate, pH 7.5, containing 6 mM DTT for 3 h. 
Determination of the amount of newly formed [3H]hypusine was done 
by oxidation with NaIO4, dimedone conversion of the oxidation prod- 
ucts and subsequent extration with toluene. 
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Fig. 2. Reconstitution of the deoxyhypusine hydroxylase by various 
transition metal ions in the presence of CPX. 3 ,uM CPX plus the 
indicated concentrations of the respective transition metal ions were 
added to the cell extracts prior to substrate incubation. The enzyme 
reaction and product determination were performed as outlined in the 
legend to Fig. 1. The residual enzyme activity after inhibition with 3pM 
CPX alone is indicated by the straight line in the lower part of the 
graph. All values are given in percent of the control value, i.e. without 
addition of CPX or metal ion. 
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Fig. 3. Reconstitution of the deoxyhypusine hydroxylase by various 
transition metal ions in the presence of EDTA. 1 /IM EDTA plus the 
indicated concentrations of the respective transition metal ions were 
added to the cell extracts prior to substrate incubation. The enzyme 
reaction and product determination were performed as outlined in the 
legend to Fig. 1. The residual enzyme activity after inhibition with 1 ,uM 
EDTA alone is indicated by the straight line in the lower part of the 
graph. All values are given in percent of the control value, i.e. without 
addition of EDTA or metal ion. 
the toluene phase. The observed 3-fold background activity 
might be explained by either a weak hydroxylation and subse- 
quent oxidation of spermidine itself or by a slow formation of 
labeled hypusine from the unmodified eIF-5A precursor, since 
crude cell extracts containing both the deoxyhypusine synthase 
and the deoxyhypusine hydroxylase were used. 
Whereas the use of [~4C]deoxyhypusine-containing substrate 
in the hydroxylase reaction results in the formation of both 
~4C-labeled formaldehyde and 14C-labeled fl-aminopropional- 
dehyde during the oxidation of the mature hypusyl residue, the 
radioactive label is only incorporated into the fl-aminopropion- 
aldehyde oxidation product, if [3H]deoxyhypusine-containing 
eIF-5A is used as substrate. Both aldehydes can be toluene 
extracted alter conversion with dimedone, since both sub- 
strates, carrying either the ]4C- or the 3H-label, give comparable 
results in the hydroxylase assay (Table 1). Moreover, a signal- 
to-noise ratio of 100:1 and a standard eviation of less than 5% 
was observed for either of the assay systems. The specific ex- 
traction of the dimedone converted aldehydes into the toluene 
phase as the final step in this assay allows a convenient and fast 
analysis of the hypusine content of the test samples. The time- 
and protein-consuming hydrolysis of elF-5A and subsequent 
Table 1 
Comparison of ~4C-labeled versus 3H-labeled substrate for monitoring the deoxyhypusine hydroxylase activity 
[lac]Assay [3H]Assay % of control 
]mean dpm value] ]mean dpm value] [~4C]/[3H] 
(+ a) (_+ or) 
n=3 n=3 
Control 
(1) Incubation without cell extract" 
(2) No NaIO4 oxidation b 
(3) [*]Spermidine + eIF-5A precursoff 
2,045 (_+ 78) 2,394 (_+ 122) 100/100 
23 (_+ 4) 19 (_+ 7) 1.1/0.8 
13 (_+ 1) 27 (+ 4) 0.7/1.1 
42 (_+ 1) 92 (_+ 4) 2.1/3.8 
~'Incubation of the radiolabeled deoxyhypusine-containing elF-5A in assay buffer and subsequent oxidation as described in legend to Fig. 1. 
bDeoxyhypusine hydroxylase reaction and assay reactions were performed as described, except hat NaIO4 was omitted from the oxidation re- 
action. 
~Incubation and subsequent oxidation of labeled spermidine plus unmodified eIF-5A (instead of radiolabeled deoxyhypusine-containing eIF-5A) as 
described above. 
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Table 2 
ICs0 values for enzyme inhibition and relative Kd values for Fe(III) of different metal chelators 
Ligand ICs0 ~' (+ o) [nM] Relative Kd -+ a b 
EDTA 279 _+ 28.7 = 1 HOOC ( COOH 
L N/'~ Nv COOH 
HOOC )
Ciclopiroxolamine 606 + 33.1 > 1000 
~ 0  
OH 
DPHP O 752 + 47.7 
N .OH 
Metipirox O 2804 + 239 
I~/N .OH 
102 _+ 39 
1+0.1 
Mimosine O 3268 + 209 
fN[~/OH 
H2 N/-,~ OH 
O 
~,cg-Dipyridyl ~ 29,173 + 192 
3_+0.5 
<3 
~'lCs0 values were calculated from data of the titration curves in Fig. 1. 
bRelative Kd values were determined by titration of their Fe(III) complexes with EDTA. 
chromatographic separation of the amino acids, the essential 
steps used in all other deoxyhypusine hydroxylase assays 
[17,19,25]), can be avoided in this assay. 
Treatment of CHO cells with different metal chelators, such 
as mimosine, kojic acid [14], ~,~'-dipyridyl, desferal [11] and 
hydralazine [19], results in a potent inhibition of the de- 
oxyhypusine hydroxylase activity in vivo. In extracts of metal 
chelator treated cells the content of fully modified hypusine was 
markedly reduced, while the amount of deoxyhypusine was 
increased. Furthermore, this inhibition of the deoxyhypusine 
hydroxylase correlates with a cell cycle arrest at the GI/S 
boundary [14,15]. Using the assay described above, the effect 
of the metal chelators EDTA, ~,cg-dipyridyl, mimosine, ci- 
clopiroxolamine (CPX), and its two derivatives metipirox and 
4,6-diphenyl-l-hydroxy-pyridine-2-one (DPHP) was investi- 
gated in vitro (Table 2). As shown in Fig. 1, all metal chelators 
inhibit the deoxyhypusine hydroxylase in vitro with ICs0 values 
in the range of 0.3-29/IM. When the crystallized Fe(III) CPX 3 
complex was tested for enzyme inhibition, no effect on the 
deoxyhypusine hydroxylase activity was observed (data not 
shown), which indicates that the inhibitory effect of the com- 
pounds tested depends on their metal ion chelating property. 
Therefore, the order of relative inhibitory potential of the chela- 
tors on the deoxyhypusine hydroxylase ( xpressed as ICs0 val- 
ues) was compared with their metal ion chelating strength, as 
measured by their relative Ka values for Fe(III). Table 2 shows 
a qualitative correlation between the decreasing IC50 values and 
the increase in relative affinity of the chelators for Fe(III). The 
only exception to this is EDTA, which shows a weaker affinity 
for Fe(III), but is the most potent inhibitor of the deoxyhypu- 
sine hydroxylase in the series of chelators investigated here. As 
it is known from other metal ion dependent hydroxylases, the 
endogenous metal ion of these enzymes changes its ionization 
state during the cataylitc ycle [20]. Since EDTA has a high 
affinity for divalent metal ions, it might exhibit its strong inhib- 
itory effect by binding the endogenous metal ion of the de- 
oxyhypusine hydroxylase in its divalent form. 
Although these experiments prove an essential role of the 
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Fig. 4. Effect of transition metal ions on the deoxyhypusine hydroxylase 
activity. The indicated concentrations of the respective transition metal 
ions were added to the cell extracts prior to substrate incubation. The 
enzyme reaction and product determination were performed as outlined 
in the legend to Fig. 1. All values are given in percent of the control 
value, i.e. without addition of metal ion. 
chelating capacity of these compounds in the inhibition of the 
deoxyhypusine hydroxylase, an additional specific interaction 
of the chelator compound with the enzyme itself cannot be 
excluded. To further investigate the mode of action of these 
chelators on the deoxyhypusine hydroxylase, reconstitution ex- 
periments using transition metal ions were performed. After 
inhibiting the deoxyhypusine hydroxylase with 3 /IM CPX, 
various amounts of Mn(II) acetate, Fe(II) sulfate, Fe(III) chlo- 
ride, Co(II) acetate, Ni(II) acetate, Cu(II) chloride, or Zn(II) 
acetate were added prior to substrate incubation. The result of 
this experiment is shown in Fig. 2. Both, Fe(II) and Fe(III) are 
equally active in reconstituting the hydroxylase activity to the 
above control levels at a concentration of 1 /~M. At higher 
concentrations, the deoxyhypusine hydroxylase activity is again 
inhibited, presumably due to unspecific binding of the ferric 
ions to the enzyme. Partial reconstitution ofthe enzyme activity 
was also observed with Cu(II) and to a lesser extend with 
Zn(II). Addition of Co(II) resulted only in a marginal reconsti- 
tution, whereas Mn([I) and Ni(II) further inhibited the de- 
oxyhypusine hydroxylase. Since a full recovery of the de- 
oxyhypusine hydroxylase was achieved by addition of either 
Fe(II) or Fe(III) the formation of a stable complex of the 
deoxyhypusine hydroxylase, the metal ion and CPX, based on 
specific binding of the chelator to the enzyme, can be excluded. 
Rather, CPX seems to form a metal ion complex, which rapidly 
dissociates from the enzyme. Therefore, the mode of action of 
CPX is due to metal ion chelation. 
The various transition metal ions differ in their capacities to 
reconstitute the deoxyhypusine hydroxylase activity. This 
might, on the one hand, indicate the specificity of the de- 
oxyhypusine hydroxylase for ferric ions. On the other hand, 
this result might also reflect differences in the relative affinities 
of CPX for these metal ions. In the latter case, binding of the 
respective metal ion to CPX might lead to the equivalent dis- 
placement of the endogenous metal ion of the deoxyhypusine 
hydroxylase from CPX, which then restores enzyme activity 
accordingly. In order to investigate his issue, a metal ion recon- 
stitution experiment was performed, using EDTA instead of 
CPX for inhibiting the deoxyhypusine hydroxylase (Fig. 3). 
Again, ferric ions were capable of fully restoring the enzyme 
activity at a concentration of 1 /.tM. Also, addition of Zn(II) 
partially restored the deoxyhypusine hydroxylase, ven though 
higher concentrations are necessary. Interestingly, also Mn(II) 
addition resulted in a partial activation of the enzyme, which 
was not observed after inhibition with CPX. Co(II), Ni(II) and 
Cu(II) did not show any activating effect. By comparing the 
results of both reconstitution experiments (Figs. 2 and 3), we 
conclude that only ferric ions show a qualitatively and quanti- 
tatively consistent effect in fully restoring the deoxyhypusine 
hydroxylase activity. The effect of the other transition metal 
ions on the activity of the deoxyhypusine hydroxylase strongly 
depended on the metal chelator used and therefore, seem to 
reflect he chelators' affinity for the respective metal ion. 
Finally, the effect of transition metal ion on the deoxyhypu- 
sine hydroxylase activity without prior inhibition by metal 
chelators was investigated. With the exception of Fe(II) and 
Fe(III), none of the metal ions showed any activating effect, but 
inhibited the enzymatic activity at concentrations of > 1 /.tM 
(Mn(II), Ni(II)) or > 10 pM (Co(II), Cu(II), Zn(II)), respec- 
tively (Fig. 4). In contrast, both Fe(II) and Fe(lII) stimulated 
the activity of the deoxyhypusine hydroxylase by 1.5-fold at a 
concentration of 1 pM. Again, at higher concentrations also 
ferric ions showed an inhibitory effect. Experiments howing 
the partial inhibition of the deoxyhypusine hydroxylase by 
transition metal ions have been previously published. However, 
the stimulating effect of ferric ions at low concentrations was 
not described, which might, in part, reflect its state of iron 
saturation [17]. 
Ferric ions were the only transition metal ions, which at a 
concentration of 1 pM stimulated the endogenous deoxyhypu- 
sine hydroxylase activity and reproducibly restored its activity, 
both after CPX and EDTA inhibition. They, therefore, appear 
to be endogenous constituents of the deoxyhypusine hydrox- 
ylase. A distinction between the relative effect of Fe(II) and 
Fe(III) was not possible, since ferric ions are only stable in their 
reduced form under the assay conditions used. Furthermore, 
the deoxyhypusine hydroxylase catalyzes a redox reaction and 
the essential endogenous metal ion also may well change its 
ionization state during the catalytic ycle. 
In agreement with several other reports [11 14,17,19] we 
found that EDTA, mimosine, ~,~-dipyridyl, CPX and its deriv- 
atives metipirox and DPHP potently inhibit the deoxyhypusine 
hydroxylase. The qualitative correlation of the 1Cs0 values for 
enzyme inhibition with the metal ion chelating properties at 
similar conditions, together with the fact that the enzyme activ- 
ity can be fully restored by addition of equimolar amounts of 
ferric ions, led us to the conclusion that this inhibition is caused 
by metal ion chelation. A specific inhibition of the deoxyhypu- 
sine hydroxylase [16] due to direct binding of the inhibitory 
compound could be excluded both for CPX and for EDTA. 
Strong metal ion chelators, like mimosine and CPX were re- 
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ported to influence a variety of cellular processes [26 29]. The 
correlation of the in vivo inhibition of the deoxyhypusine hy- 
droxylase, the arrest of the cell cycle at the GI /S boundary [14], 
and the non assembly of certain mRNAs into polysomes 
observed after mimosine treatment [15] should, therefore, be 
cautiously interpreted. 
With the rapid and specific assay for the deoxyhypusine 
hydroxylase presented, the enzymatic mechanism of the de- 
oxyhypusine hydroxylase and its inhibition by polyamines [13] 
can further be investigated. Moreover, this assay technique 
considerably facilitates the establishment of a purification pro- 
tocol for this enzyme. 
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